Research Article
Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer
Table 3
Distribution of weight gain 6 months following randomization, stratified by treatment received and body mass index.
| | | RT only () | RT + ADT () | | | Weight change 6 months following randomization | | | <10 lbs () |
≥10 lbs () | <10 lbs () | ≥10 lbs () |
| | BMI (range in kg/m2) | (Range −13 to +9; median −1 lb) | (Range 10 to 13; median +11.5 lbs) | (Range −11 to +8; median +1 lb) | (Range 10 to 17 lbs; median +11.25 lbs) | | Normal (18.5–24.9) | 17 (20%) | 1 (50%) | 22 (29%) | 2 (20%) | | Overweight (25.0–29.9) | 43 (52%) | 1 (50%) | 37 (49%) | 1 (10%) | | Obese (≥30.0) | 23 (28%) | 0 (0%) | 17 (22%) | 7 (70%) | | | Fisher’s exact test value = 0.45 | Fisher’s exact test value = 0.006 |
|
|
RT indicates radiotherapy; ADT: androgen deprivation therapy; BMI: body mass index.
|
